These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 34706782)
1. Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Lin D; Hu B; Li P; Zhao Y; Xu Y; Wu D Exp Hematol Oncol; 2021 Oct; 10(1):49. PubMed ID: 34706782 [TBL] [Abstract][Full Text] [Related]
2. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation. Fujiwara H Front Immunol; 2021; 12():703298. PubMed ID: 34512627 [TBL] [Abstract][Full Text] [Related]
3. The composition of the intestinal microbiota after allogeneic haematopoietic stem cell transplantation and its association with graft versus host disease as assessed by 16Sribosomal ribonucleic acid. Li DS; Wu YR; Du WH; Zhu YL; Zhang WJ; Fu Y; Yang GB J Physiol Pharmacol; 2023 Feb; 74(1):. PubMed ID: 37245237 [TBL] [Abstract][Full Text] [Related]
4. The role of microbiota in allogeneic hematopoietic stem cell transplantation. Chang CC; Hayase E; Jenq RR Expert Opin Biol Ther; 2021 Aug; 21(8):1121-1131. PubMed ID: 33412949 [TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and acute graft-versus-host disease. Yoshioka K; Kakihana K; Doki N; Ohashi K Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475 [TBL] [Abstract][Full Text] [Related]
6. Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease. Yue X; Zhou H; Wang S; Chen X; Xiao H Cancer Med; 2024 Feb; 13(3):e6799. PubMed ID: 38239049 [TBL] [Abstract][Full Text] [Related]
7. A Promising Insight: The Potential Influence and Therapeutic Value of the Gut Microbiota in GI GVHD. Li J; Zhang X; Chen Y; Zheng Q; Zhao M; Jiang H Oxid Med Cell Longev; 2022; 2022():2124627. PubMed ID: 35571252 [TBL] [Abstract][Full Text] [Related]
8. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD. Köhler N; Zeiser R Front Immunol; 2018; 9():3179. PubMed ID: 30705680 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease. van Lier YF; Vos J; Blom B; Hazenberg MD Gut Microbes; 2023; 15(1):2178805. PubMed ID: 36794370 [TBL] [Abstract][Full Text] [Related]
10. Effect of GVHD on the gut and intestinal microflora. Ji H; Feng S; Liu Y; Cao Y; Lou H; Li Z Transpl Immunol; 2024 Feb; 82():101977. PubMed ID: 38184214 [TBL] [Abstract][Full Text] [Related]
11. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature. Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation. Whangbo J; Ritz J; Bhatt A Bone Marrow Transplant; 2017 Feb; 52(2):183-190. PubMed ID: 27526283 [TBL] [Abstract][Full Text] [Related]
13. Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis. Riwes M; Reddy P Semin Hematol; 2020 Jan; 57(1):1-6. PubMed ID: 32690138 [TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics. Gray AN; DeFilipp Z Transplant Cell Ther; 2023 Aug; 29(8):484-491. PubMed ID: 37169290 [TBL] [Abstract][Full Text] [Related]